Pengaruh Deferasirox Terhadap Kadar T4 dan TSH Pada B-Thalassemia Mayor dengan Kadar Ferritin Tinggi
Latar belakang. Iron overload pada pasien -thalassemia mayor terjadi akibat transfusi berulang. Pengendapan besi terjadi terutama di jantung, hati dan kelenjar endokrin. Prevalensi hipotiroid akibat toksisitas besi pada pasien -thalassemia berkisar 0-35%. Terapi kelasi besi seperti deferasirox san...
Main Authors: | Dewi Ratih P, Rudy Susanto, Bambang Sudarmanto |
---|---|
Format: | Article |
Language: | Indonesian |
Published: |
Badan Penerbit Ikatan Dokter Anak Indonesia
2016-11-01
|
Series: | Sari Pediatri |
Subjects: | |
Online Access: | https://saripediatri.org/index.php/sari-pediatri/article/view/482 |
Similar Items
-
ANALYSIS OF DEFERASIROX AND DEFERIPRON USE IN CHILDREN WITH PEDIATRIC -THALASSEMIA MAJOR
by: Evy Sari Sutrisnaningsih, et al.
Published: (2017-08-01) -
Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
by: Shahla Ansari, et al.
Published: (2017-06-01) -
Renal function in patients with thalassemia major receiving Exjade® dispersible tablets and a new film-coated tablet formulation of deferasirox (Nanojade®)
by: Vahid Falahati, et al.
Published: (2022-01-01) -
Comparison of the Mean Serum Ferritin Levels in Thalassaemia Major Patients after Giving Deferasirox and Deferoxamine
by: Seema Aftab, et al.
Published: (2017-12-01) -
Comparison of the effects of deferasirox film-coated tablets (Jadenu®) and deferasirox dispersible tablets (Exjade®) in patients with beta thalassemia major: a preliminary report of the effects on the satisfaction, convenience, cardiac/liver MRI T2*, serum ferritin level, and biochemical profiles
by: Mahya Mobinikhaledi, et al.
Published: (2024-11-01)